FDA Approves LURASIDONE HYDROCHLORIDE — Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited announced that the FDA has approved its ANDA for lurasidone hydrochloride oral tablets, broadening its portfolio of antipsychotic treatments. This approval is anticipated to secure competitive market positioning and drive incremental revenue gains from generic substitution in the schizophrenia sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day